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Abstract
In polycystic ovary syndrome (PCOS), cardiovascular risk is increased. Peak
O2 uptake ( _VO2peak) predicts the cardiovascular risk. We were the first to
examine the contribution of systemic O2 delivery and arteriovenous O2 differ-
ence to _VO2peak in overweight and obese women with PCOS. Fifteen over-
weight or obese PCOS women and 15 age-, anthropometry-, and physical
activity-matched control women performed a maximal incremental cycling
exercise test. Alveolar gas exchange (volume turbine and mass spectrometry),
arterial O2 saturation (pulse oximetry), and cardiac output (CO) (impedance
cardiography) were monitored. Hb concentration was determined. Arterial O2
content and arteriovenous O2 difference (C(a-v)O2) (Fick equation) were cal-
culated. Insulin resistance was evaluated by homeostasis model assessment
(HOMA-IR). PCOS women had lower _VO2peak than controls (40  6 vs.
46  5 mL/min/kg fat-free mass [FFM], P = 0.011). Arterial O2 content was
similarly maintained in the groups throughout the exercise test (P > 0.05).
Linear regression analysis revealed a pronounced response of CO to increasing
_VO2 in PCOS women during the exercise test: A ΔCO/Δ _VO2 slope was stee-
per in PCOS women than in controls (b = 5.84 vs. b = 5.21, P = 0.004).
Eventually, the groups attained similar peak CO and peak CO scaled to FFM
(P > 0.05). Instead, C(a-v)O2 at peak exercise was lower in PCOS women
than in controls (13.2  1.6 vs. 14.8  2.4 mL O2/100 mL blood, P = 0.044).
HOMA-IR was similar in the groups (P > 0.05). The altered cardiorespiratory
responses to exercise in overweight and obese PCOS women indicate that
PCOS per se is associated with alterations in peripheral adjustments to exer-
cise rather than with limitations of systemic O2 delivery.
Introduction
Polycystic ovary syndrome (PCOS) is a complex
endocrinopathy characterized by chronic oligo-anovula-
tion, polycystic ovaries, and hyperandrogenism (Goodarzi
et al. 2011). PCOS affects from 6% to 20% of women
worldwide, depending on the population studied and
diagnostic criteria applied (Azziz et al. 2004; Broekmans
et al. 2006; Boyle et al. 2012). Hence, it is the most com-
mon endocrinopathy in reproductive-aged women. Insu-
lin resistance (IR) and concomitant compensatory
hyperinsulinemia drive the phenotypic features of PCOS
and thus are essential characteristics of the syndrome
(Goodarzi et al. 2011). PCOS involves both intrinsic
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syndrome-specific IR and extrinsic body mass index
(BMI)-related IR in overweight and obese women (Stepto
et al. 2013). Overweight (25 kg/m2 ≤ BMI < 30 kg/m2)
and obesity (BMI ≥ 30 kg/m2) affect over 50% of women
with PCOS and exacerbate both reproductive abnormali-
ties and metabolic dysfunction (Azziz et al. 2009).
Metabolic dysfunction in women with PCOS leads to
exaggerated risk for diabetes and cardiovascular diseases
with aging (The Amsterdam ESHRE/ASRM-Sponsored
3rd PCOS Consensus Workshop Group, 2012). Peak O2
uptake ( _VO2peak) reflects exercise capacity, which is an
independent predictor of cardiovascular and all-cause
mortality in women (Mora et al. 2003). Overweight and
obese women with PCOS have reduced _VO2peak compared
to age- and BMI-matched healthy women (Orio et al.
2006). However, if exhibiting a similar IR profile, over-
weight and obese women with PCOS have been reported
to have similar _VO2peak to that of age- and weight-
matched healthy women (Thomson et al. 2009). Thus,
the magnitude of IR has been suggested to be the leading
pathophysiological feature affecting _VO2peak in overweight
and obese women with PCOS (Orio et al. 2006; Thomson
et al. 2009).
_VO2 is a product of cardiac output (CO) and systemic
arteriovenous O2 difference (C(a-v)O2). In an integrated
manner, _VO2 consists of the O2 transport system deliver-
ing O2 from the air to the muscle mitochondria and the
metabolic system utilizing the delivered O2 to generate
energy. Hence, _VO2peak may be affected by limitations of
alveolar gas exchange, Hb concentration, cardiac function,
muscle blood flow, muscle O2 extraction, and muscle O2
utilization (Wagner 2000). However, little is known about
mechanisms primarily determining _VO2peak in PCOS.
Both diastolic (Yarali et al. 2001; Orio et al. 2004; Kos-
mala et al. 2008) and systolic (Kosmala et al. 2008) dys-
function, associated with IR (Yarali et al. 2001; Orio et al.
2004; Kosmala et al. 2008), as well as normal cardiac
function (Tekin et al. 2009; Rees et al. 2014) have been
reported in women with PCOS at rest in case–control
echocardiographic studies. Thus, cardiac dysfunction and
concomitantly impaired exercise CO are potential con-
tributors to reduced _VO2peak in PCOS. Peripheral O2
delivery and utilization may also be affected in PCOS.
Women with PCOS exhibit endothelial dysfunction mani-
fested as impaired nitric oxide (NO)-mediated vasodila-
tion (Sprung et al. 2013a,b), which can result in impaired
muscle blood flow during exercise (Maxwell et al. 1998).
For the present, an association between endothelial dys-
function and IR in PCOS is unresolved (Sprung et al.
2013a). Defects in skeletal muscle insulin signaling path-
ways (Dunaif et al. 2001; Corbould et al. 2005) and
expression of genes involved in mitochondrial oxidative
metabolism (Skov et al. 2007) have also been observed in
women with PCOS and pronounced IR, potentially
reducing responsiveness to glucose and O2 utilization
within skeletal muscles. However, intact primary function
of skeletal muscle mitochondria has also been reported in
PCOS (Eriksen et al. 2011; Rabøl et al. 2011).
Characterizing and understanding cardiorespiratory and
vascular responses to exercise in women with PCOS is
important as lifestyle management, including regular exer-
cise and diet, is the first-line strategy in pursuing health
outcomes (e.g., improved ovulation and menstrual cycle
regulation, reduced weight and IR) in PCOS (Harrison
et al. 2011). Nevertheless, the responses of cardiac function
and C(a-v)O2 to exercise in women with PCOS have not
yet been studied. In this study, we hypothesized that over-
weight and obese PCOS women would have lower _VO2peak
than control women matched for age, anthropometry, and
leisure-time physical activity (LTPA). The purpose of the
study was to examine systemic O2 delivery (particularly
cardiac function) and C(a-v)O2 during incremental exer-
cise and their contributions to the hypothetically reduced
_VO2peak of overweight and obese PCOS women.
Materials and Methods
Subjects
Thirty female volunteers participated in this study. Fifteen
subjects were overweight or obese PCOS women, while 15
subjects were overweight or obese control women. The
groups were matched for age, anthropometry, and self-
reported LTPA. All subjects were Finns and thus had a
North European background. PCOS women achieved the
European Society for Human Reproduction and Embryol-
ogy/American Society for Reproductive Medicine criteria
for PCOS diagnosis (i.e., Rotterdam criteria) (Rotterdam
ESHRE/ASRM-Sponsored PCOS Consensus Workshop
Group, 2004): All showed oligo- or anovulation, all
showed polycystic ovaries on transvaginal ultrasound, and
four had clinical (hirsutism) and/or biochemical (serum
testosterone > 2.0 nmol/L) hyperandrogenism. PCOS
women were recruited from the patient population of the
Department of Obstetrics and Gynecology, Helsinki
University Hospital, Helsinki, Finland. Controls were reg-
ularly menstruating (i.e., a menstrual period occurring
every 23–32 days [Cole et al. 2009]), showed no clinical
evidence of hyperandrogenism, and were free of medica-
tion. Controls were mainly recruited from the employees
and the students of University of Helsinki, Helsinki, Fin-
land. The exclusion criteria of the study were an age of
<18 or >40 years, BMI of <25 or >40 kg/m2, pregnancy,
androgen-secreting tumors, congenital adrenal hyper-
plasia, Cushing’s syndrome, anemia, diabetes,
hypertension, antiandrogen medication, b-blocker medi-
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cation, medication influencing glucose homeostasis, use
of oral contraceptives, substance abuse, physical disability,
smoking, and other cardiovascular, endocrine, muscu-
loskeletal, neurological, or respiratory diseases that could
have affected any outcome of interest.
Ethical approval
Every subject gave written informed consent to participate
in this study, which conformed to the Declaration of
Helsinki and was approved by the Ethics Committee of
Hospital District of Helsinki and Uusimaa, Helsinki,
Finland.
Study protocol
The subjects visited the laboratory twice. Both visits were
preceded by abstinence from alcohol for at least 24 h and
physical exercise for at least 12 h. At the first visit, the sub-
jects reported to the laboratory 2–3 h after a meal. The
first visit consisted of pre-exercise measurements and a
cardiorespiratory exercise test. The subjects completed a
preliminary questionnaire concerning their personal health
and medical history. LTPA was obtained from a single
question: “If you think about your past 3 months and
physical activity sessions lasting more than 20 min in all
settings (e.g., commutation, walking a dog, recreation,
sport), how many times a week and how long at a time
have you engaged in physical activity?” The question meets
the general recommendations (i.e., frequency, duration, all
settings) for enquiring LTPA (van Poppel et al. 2010). The
subjects’ height and waist and hip circumferences were
measured, and body composition was determined by the
bioimpedance method (InBody 720, Biospace Co., Ltd.,
Seoul, South Korea). Capillary blood was drawn from a
fingertip to analyze Hb concentration by a blood gas ana-
lyzer (ABL725, Radiometer, Copenhagen, Denmark). Pre-
exercise measurements at rest also included a 12-lead
ECG, blood pressure, and flow-volume spirometry (Med-
ikro Spiro 2000, Medikro Oy, Kuopio, Finland). In addi-
tion, a physician examined the subjects to ensure their
suitability for the cardiorespiratory exercise test, which
was also performed at the first visit (see below).
The second visit followed overnight fasting. Fasting
venous blood was drawn for measurements of lipid profile
(i.e., HDL, LDL, and total cholesterol and triglycerides),
plasma glucose, and serum insulin. Fasting plasma glucose
and fasting serum insulin were determined by the hexoki-
nase method and the immunochemiluminometric assay,
respectively. Homeostasis model assessment of IR
(HOMA-IR) was calculated by the following formula (Mat-
thews et al. 1985): HOMA-IR = [fasting plasma glucose
(mmol/L)] 9 [fasting serum insulin (lU/mL)]/22.5.
Serum testosterone and sex hormone-binding globulin
(SHBG) concentrations of PCOS women were not deter-
mined separately for this study but as part of the patients’
clinical care by the mass spectrometry assay and the
immunochemiluminometric assay, respectively. Free
androgen index was calculated as follows: Free androgen
index = [serum testosterone (nmol/L)]/[serum SHBG
(nmol/L)] 9 100.
Cardiorespiratory exercise test
The cardiorespiratory exercise test was performed on a
mechanically braked cycle ergometer (Monark Ergomedic
839E, Monark Exercise AB, Vansbro, Sweden). The test
began with 5-min seated rest while the subjects sat relaxed
on the ergometer, followed by 5-min baseline unloaded
cycling. The step incremental protocol (30 W/3 min) was
then initiated with a work rate of 30 W, and the subjects
continued exercising until volitional fatigue. The subjects
were verbally encouraged to maximal exertion.
Breath-by-breath ventilation was measured by a low-
resistance turbine (Triple V, Jaeger Mijnhardt, Bunnik,
The Netherlands) to determine inspiratory and expiratory
volumes and flow during the exercise test. Prior to each
test, the turbine was calibrated using a syringe of 3.00 L
volume (Hans Rudolph, Inc., Kansas City, MO). Inspired
and expired gases were sampled continuously at mouth
and analyzed for concentrations of O2, CO2, N2, and Ar
by mass spectrometry (AMIS 2000, Innovision A/S,
Odense, Denmark) after calibration with precision-ana-
lyzed gas mixtures. Breath-by-breath respiratory data were
collected as raw data. The raw data were transferred to a
computer, which determined gas delays for each breath to
align concentrations with volume data and to build a
profile of each breath. Breath-by-breath alveolar gas
exchange was then calculated with the AMIS algorithms,
and the data were interpolated to obtain second-by-sec-
ond values. Respiratory exchange ratio (RER) was calcu-
lated as a quotient of CO2 output and pulmonary O2
uptake ( _VO2) (Edvardsen et al. 2014). Rating of perceived
exertion (RPE) was obtained using the Borg scale (6–20)
at the end of each work rate.
Fingertip pulse oximetry (Nonin 9600, Nonin Medical,
Inc., Plymouth, MA) was used to monitor arterial O2
saturation (SpO2). Arterial O2 content (CaO2) was calcu-
lated as the product of SpO2, Hb concentration, and the
physiological O2 binding coefficient of Hb (1.34 mL/g):
CaO2 = SpO2 9 Hb concentration 9 1.34.
Heart rate (HR) and the electrical activity of the heart
were continuously monitored by ECG (PowerLab,
ADInstruments, Oxford, United Kingdom). Cardiac func-
tion was continuously evaluated by an impedance cardio-
graph device (PhysioFlow, Manatec Biomedical, Paris,
ª 2016 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
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France). This method has been described in detail else-
where (Charloux et al. 2000); briefly, the method uses
changes in transthoracic impedance during cardiac ejection
to calculate stroke volume (SV), which is multiplied by
HR to provide an estimate of CO. The method has been
found valid and reliable at rest and during low-to-maximal
intensity exercise in overweight and obese individuals
(Charloux et al. 2000; Richard et al. 2001); when CO has
been measured by the PhysioFlow and the direct Fick
method during maximal incremental exercise, a correlation
coefficient of r = 0.94 between the two methods has been
observed (Richard et al. 2001). Systolic and diastolic blood
pressures were measured automatically (Tango+, SunTech
Medical, Morrisville, NC) from the brachial artery at
seated rest and at the end of each work rate.
Mean arterial pressure (MAP) was calculated by the
standard equation: MAP = (systolic blood pres-
sure + 2 9 diastolic blood pressure)/3. Systemic vascular
resistance (SVR) was calculated according to Darcy’s law:
SVR = (MAP  central venous pressure)/CO, where cen-
tral venous pressure was assumed to be 0 mmHg (Mor-
tensen et al. 2005). Cardiac power output (CPO) at peak
exercise was calculated from the values of CO and MAP
at peak exercise (Cooke et al. 1998): CPO = CO 9
MAP 9 K, where K is a conversion factor (2.22 9 103)
into watts. Systemic C(a-v)O2 was derived using the Fick
equation: C(a-v)O2 = _VO2/CO.
Statistical analysis
Data are expressed as mean  standard deviation (SD).
The mean values of the last 30 sec at seated rest, during
unloaded cycling, at each work rate, and at peak exercise
were chosen for further analyses. Peak O2 uptake
( _VO2peak) was determined as the highest value of a 60-sec
moving averaging interval.
The Shapiro–Wilk test was used to check for normality
and data were log transformed when appropriate. A one-
Table 1. Baseline characteristics of the subjects and cardiovascu-
lar function at seated rest.
PCOS
(n = 15)
Controls
(n = 15) P
Baseline characteristics
Age (years) 29.3  4.0 31.1  5.5 0.326
Height (cm) 171  6 167  10 0.166
Weight (kg) 94  8 86  17 0.121
Body mass index (kg/m2) 32.0  2.0 30.6  3.9 0.208
Body fat (%) 41  4 39  6 0.386
Fat-free mass (kg) 55  5 52  8 0.106
Waist-to-hip ratio 0.86  0.07 0.83  0.08 0.279
Leisure-time physical
activity (h:min/wk)
2:22  1:02 2:33  1:19 0.691
Hb concentration (g/L) 132  9 134  7 0.685
FVC (L) 4.2  0.4 4.3  0.7 0.743
FVC (% of reference value) 96  8 103  14 0.105
FEV1 (L) 3.5  0.4 3.4  0.5 0.623
FEV1 (% of reference value) 92  8 95  11 0.352
Cardiovascular function at seated rest
Systolic blood
pressure (mmHg)
116  8 116  17 0.979
Diastolic blood
pressure (mmHg)
82  8 76  10 0.078
HR (bpm) 86  12 79  12 0.120
SV (mL) 73  11 66  12 0.073
SVi (mL/kg FFM) 1.33  0.22 1.29  0.25 0.655
CO (L/min) 6.2  0.8 5.2  1.1 0.006
COi (mL/min/kg FFM) 114  20 101  18 0.071
Data are means  SD.
FVC, forced vital capacity; FEV1, forced expiratory volume in 1 sec;
HR, heart rate; SV, stroke volume; SVi, stroke volume index; FFM,
fat-free mass; CO, cardiac output; COi, cardiac output index.
Table 2. Metabolic profile and cardiovascular risk factors of the
subjects.
PCOS
(n = 15)
Controls
(n = 15) P
Fasting glucose (mmol/L) 5.4  0.41 5.5  0.6 0.814
Fasting insulin (lU/mL) 12.1  6.91 10.0  4.4 0.356
HOMA-IR 3.0  1.81 2.5  1.3 0.442
HDL cholesterol (mmol/L) 1.3  0.3 1.6  0.4 0.043
LDL cholesterol (mmol/L)2 3.0  0.8 3.0  0.9 0.764
Total cholesterol (mmol/L) 4.6  0.7 4.7  0.9 0.604
Triglycerides (mmol/L) 1.1  0.5 1.0  0.4 0.496
Data are means  SD.
1n = 14.
2Log transformed for statistical analysis due to non-normally dis-
tributed data.
HOMA-IR, homeostasis model assessment index of insulin resis-
tance.
Figure 1. Pulmonary O2 uptake scaled relative to fat-free mass ( _VO2) (A), arterial O2 content (CaO2) (B), heart rate (HR) (C), stroke volume
index (SVi) (D), cardiac output index (COi) (E), mean arterial pressure (MAP) (F), systemic vascular resistance index (SVRi) (G), and arteriovenous
O2 difference (C(a-v)O2) (H), as a function of work rate. White circles (○) = PCOS women (n = 15), black circles (●) = controls (n = 15). The P
values refer to a two-way repeated measures ANOVA: Group 9 Exercise interaction is evaluated, while Group (PCOS women vs. controls) is a
between-subjects factor and Exercise (unloaded cycling [0 W], work rates accomplished by each subject [30 W, 60 W, 90 W, 120 W], peak
exercise) is a within-subject factor. *Post hoc significantly different from PCOS women at P < 0.05.
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way ANOVA was used to compare baseline characteristics,
cardiovascular function at seated rest, metabolic profile,
cardiovascular risk factors, and CPO between PCOS
women and controls. A two-way repeated measures
ANOVA was used to evaluate whether there were differ-
ences in responses to the cardiorespiratory exercise test
between PCOS women and controls: Group 9 Exercise
interactions were evaluated, while Group (i.e., PCOS
women vs. controls) was a between-subjects factor, and
Exercise (i.e., unloaded cycling [0W], work rates accom-
plished by each subject [30 W, 60 W, 90 W, 120 W], peak
exercise) was a within-subject factor. In a separate analysis,
we used relative intensities (i.e., % of _VO2peak during
unloaded cycling [0 W], 25% of _VO2peak, 50% of _VO2peak,
75% of _VO2peak, 100% of _VO2peak) as a within-subject fac-
tor. Multivariate ANOVA with Bonferroni post hoc analy-
sis was performed to identify the differences in the exercise
responses between PCOS women and controls. Pearson’s
correlation coefficient was used for correlation analyses.
The response of CO to incremental exercise was deter-
mined as follows: The means of CO and _VO2 at six data
points (i.e., unloaded cycling [0 W], 30 W, 60 W, 90 W,
120 W, peak exercise) were separately calculated for
PCOS women and controls, after which the ΔCO/Δ _VO2
slope for both subject groups was determined by perform-
ing a linear regression of CO over _VO2 at the six data
points. Further comparison of the ΔCO/Δ _VO2 slopes (i.e.,
the b coefficients) between PCOS women and controls
was made by using the method of dummy variables and
interaction terms (Lunt 2015): A dummy variable called
Syndrome was first created so that it took the value 0 for
controls and 1 for PCOS women. To test whether PCOS
affected the linear regression of CO over _VO2, an interac-
tion term Syndrome 9 _VO2 was created and then
Figure 2. Heart rate (HR) (A), stroke volume index (SVi) (B), cardiac output index (COi) (C), and arteriovenous O2 difference (C(a-v)O2) (D), as a
function of relative intensity (% of peak pulmonary O2 uptake [ _VO2peak]). White circles (○) = PCOS women (n = 15), black circles
(●) = controls (n = 15). The P values refer to a two-way repeated measures ANOVA: Group 9 Exercise interaction is evaluated, while Group
(PCOS women vs. controls) is a between-subjects factor and Exercise (% of _VO2peak during unloaded cycling [0 W], 25% of _VO2peak, 50% of
_VO2peak, 75% of _VO2peak, 100% of _VO2peak) is a within-subject factor. *Post hoc significantly different from PCOS women at P < 0.05.
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included in an additional multiple linear regression
model, where CO was the outcome, and Syndrome, _VO2,
and Syndrome 9 _VO2 were the predictors. Eventually,
the contribution of Syndrome 9 _VO2 to the model indi-
cated whether the ΔCO/Δ _VO2 slopes differed between
PCOS women and controls.
To avoid ignoring any differences in body size and
composition between PCOS women and controls, we
scaled _VO2 (Batterham et al. 1999; Krachler et al. 2015)
as well as SV, CO, and CPO (Whalley et al. 2004) relative
to fat-free mass (FFM), whereas SVR was multiplied by
FFM. The scaled cardiovascular variables were referred as
indices: SVi, COi, CPOi, SVRi, respectively.
Statistical significance was set at a P value of <0.05.
The results were computed with PASW Statistics 18.0
(IBM Corporation, Somers, NY).
Results
Descriptive characteristics of the subjects
Baseline characteristics, cardiovascular function at seated
rest, metabolic profile, and cardiovascular risk factors of
the subjects are summarized in Tables 1 and 2. PCOS
women and controls had similar Hb concentrations and
flow-volume spirometry results with no defects. No differ-
ences between the groups were observed for systolic and
diastolic blood pressures, HR, SV, and SVi at rest. At rest,
PCOS women had higher CO, but similar COi in compar-
ison with controls. Fasting glucose, fasting insulin, HOMA-
IR, LDL cholesterol, total cholesterol, and triglycerides
were similar between the groups. PCOS women had lower
HDL cholesterol than controls. In PCOS women, serum
testosterone was 1.4  0.7 nmol/L, serum SHBG was
40  17 nmol/L, and free androgen index was 4.3  4.0.
Responses to cardiorespiratory exercise test
_VO2 and cardiovascular responses to the incremental
exercise test are presented in Figures 1 and 2. Table 3
details peak work rates as well as respiratory and cardio-
vascular responses at peak exercise. A significant
Group 9 Exercise interaction was observed for _VO2
(P = 0.014; Fig. 1A). When scaled to FFM, peak work
rate and _VO2peak were lower in PCOS women than in
controls, while the differences in absolute values were not
significant. At peak exercise, RER (1.12  0.05 vs.
1.12  0.05, P = 0.845) and RPE (20  1 vs. 19  1,
P = 0.346) were similar between PCOS women and con-
trols, respectively, indicating that both groups similarly
made their maximal effort during the exercise test.
No difference between PCOS women and controls were
observed for ventilation at peak exercise. SpO2 and CaO2
were also similarly maintained in the groups throughout
the exercise test.
Similar profiles of HR, SVi, COi, MAP, and SVRi as a
function of work rate, and similar profiles of HR, SVi,
and COi as a function of relative intensity (% of _VO2peak)
were seen in PCOS women and controls throughout the
exercise: Significant Group9Exercise interactions in these
analyses were not observed. In addition, similar HR, SV,
SVi, CO, COi, systolic blood pressure, diastolic blood
pressure, MAP, SVR, SVRi, CPO, and CPOi were detected
in the groups at peak exercise.
Hyperbolic responses of C(a-v)O2 to incremental exercise
were seen in PCOS women and controls (Figs. 1H and 2D).
Group 9 Exercise interactions for C(a-v)O2 (P = 0.075
when examining C(a-v)O2 as a function of work rate, and
P = 0.052 when examining C(a-v)O2 as a function of % of
_VO2peak; Figs. 1H and 2D) suggested there might be true
group effects at single work rates or relative intensities
Table 3. Work rates and respiratory and cardiovascular responses
at peak exercise.
PCOS
(n = 15)
Controls
(n = 15) P
Work rate (W) 168  22 177  37 0.406
Work rate (W/kg FFM) 3.0  0.3 3.5  0.5 0.015
_VO2 (L/min) 2.22  0.27 2.36  0.39 0.264
_VO2 (mL/min/kg) 24  3 28  5 0.006
_VO2 (mL/min/kg FFM) 40  6 46  5 0.011
Ventilation (L/min) 89.5  7.5 96.6  16.3 0.136
SpO2 (%) 97  2 96  2 0.185
CaO2 (mL O2/100 mL blood) 17.2  1.3 17.2  0.9 0.933
HR (bpm) 179  12 180  6 0.768
SV (mL) 95  13 89  15 0.224
SVi (mL/kg FFM) 1.74  0.32 1.73  0.22 0.945
CO (L/min) 17.0  2.2 16.0  2.7 0.259
COi (mL/min/kg FFM) 310  55 312  36 0.941
Systolic blood
pressure (mmHg)
176  18 167  21 0.231
Diastolic blood
pressure (mmHg)
83  17 87  13 0.943
MAP (mmHg) 114  15 111  12 0.537
SVR (mmHg/L∙min) 6.8  1.4 7.1  1.4 0.587
SVRi (mmHg/L∙min∙kg FFM) 383  99 363  74 0.543
C(a-v)O2 (mL O2/100
mL blood)
13.2  1.6 14.8  2.4 0.044
CPO (W) 4.3  0.7 4.0  0.8 0.213
CPOi (W/FFM) 0.08  0.01 0.08  0.01 0.733
Data are means  SD.
FFM, fat-free mass; _VO2, pulmonary O2 uptake; SpO2, arterial O2
saturation; CaO2, arterial O2 content; HR, heart rate; SV, stroke
volume; SVi, stroke volume index; CO, cardiac output; COi, cardiac
output index; MAP, mean arterial pressure; SVR, systemic vascular
resistance; SVRi, systemic vascular resistance index; C(a-v)O2, sys-
temic arteriovenous O2 difference; CPO, cardiac power output;
CPOi, cardiac power output index.
ª 2016 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
the American Physiological Society and The Physiological Society.
2016 | Vol. 4 | Iss. 4 | e12719
Page 7
A. P. E. Rissanen et al. Acute Exercise and Polycystic Ovary Syndrome
regarding C(a-v)O2. Consequently, PCOS women had
lower C(a-v)O2 at peak exercise than controls (Figs. 1H
and 2D, Table 3). Additionally, the ΔCO/Δ _VO2 slope was
steeper in PCOS women when compared to controls
(b = 5.84 vs. b = 5.21, respectively, P = 0.004; Fig. 3).
In all subjects, an inverse correlation between _VO2peak
(mL/min/kg FFM) and HOMA-IR was observed, but it
did not reach statistical significance (r = 0.29,
P = 0.066). Instead, when _VO2peak was scaled relative to
body weight, there was a significant correlation between
_VO2peak and HOMA-IR in all subjects (r = 0.34,
P = 0.037). When the correlation between _VO2peak (mL/
min/kg FFM) and HOMA-IR was examined separately in
PCOS women and controls, no significant correlation cof-
ficients were observed: r = 0.29 (P = 0.155) in PCOS
women and r = 0.19 (P = 0.247) in controls.
Discussion
According to our hypothesis, reduced _VO2peak was
observed in overweight and obese women with PCOS
when compared to that of age-, anthropometry-, and
LTPA-matched controls. To explain this, two novel find-
ings were made. First, reduced C(a-v)O2 at peak exercise
and a steeper ΔCO/Δ _VO2 slope in PCOS women reflected
an altered response to incremental exercise in comparison
with controls. Second, PCOS women and controls
attained similar cardiac function at peak exercise, while
CaO2 was similarly maintained in the groups throughout
the exercise. These findings in the relatively healthy over-
weight and obese women indicate that PCOS per se is
associated with alterations in peripheral adjustments
to exercise rather than with limitations of systemic O2
delivery.
Altered cardiorespiratory response to
exercise in PCOS women: reduced _VO2peak,
reduced C(a-v)O2 at peak exercise, steeper
ΔCO/Δ _VO2 slope
We observed lower _VO2peak in PCOS women than in con-
trols, while there was no significant difference in HOMA-
IR between the groups. Previously, reduced _VO2peak in
overweight and obese women with PCOS has been
reported when compared to age- and BMI-matched
healthy women (Orio et al. 2006), but if exhibiting a sim-
ilar IR profile, obese women with PCOS have been found
to have similar _VO2peak to that of age- and weight-
matched healthy women (Thomson et al. 2009). In addi-
tion, an inverse association between _VO2peak and HOMA-
IR has been reported in women with PCOS (Orio et al.
2006) and in a pooled population including obese women
with and without PCOS (Thomson et al. 2009). Hence, it
has been hypothesized that IR would be significantly
linked to _VO2peak in overweight and obese women with
PCOS (Orio et al. 2006; Thomson et al. 2009). However,
_VO2peak has been scaled to body weight in the two studies
(Orio et al. 2006; Thomson et al. 2009), which ignores
body composition and thus may introduce a bias against
overweight and obese women (Krachler et al. 2015) as
discussed later. An inverse association between FFM-
adjusted _VO2peak (mL/min/kg FFM) and HOMA-IR did
not reach statistical significance in our study. Instead,
when _VO2peak was scaled to body weight, the association
between _VO2peak and HOMA-IR in all subjects turned out
significant. Taken together, it seems that IR is likely
linked to the reduced _VO2peak in overweight and obese
women with PCOS but the link becomes weaker when
the confounding effect of adipose tissue is taken into
account. This suggests that other pathophysiological fea-
tures, not related to IR, also have a significant impact on
_VO2peak in women with PCOS.
In addition to the reduced _VO2peak, we observed both
reduced C(a-v)O2 at peak exercise and a steeper ΔCO/
Δ _VO2 slope in PCOS women when compared to controls.
C(a-v)O2 also tended to be lower in PCOS women than in
controls throughout the exercise until reaching the signifi-
cant difference at peak exercise (Figs. 1H and 2D). These
findings indicate that PCOS women exhibited a pro-
nounced response of CO to increasing O2 demand from
Figure 3. Linear regression lines presenting mean responses of
cardiac output (CO) to increasing pulmonary O2 uptake ( _VO2)
during incremental exercise. White circles (○) = PCOS women
(n = 15), black circles (●) = controls (n = 15). The six data points
for both PCOS women and controls indicate the group means of
CO and _VO2 during unloaded cycling (0 W), at work rates of
30 W, 60 W, 90 W, and 120 W, and at peak exercise. The ΔCO/
Δ _VO2 slopes for both groups have been determined by performing
a linear regression of CO over _VO2 at the six data points. *The P
value refers to the significantly different ΔCO/Δ _VO2 slopes between
PCOS women (b = 5.84) and controls (b = 5.21).
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the very beginning of incremental exercise to compensate
for alterations in peripheral adjustments to exercise.
We hypothesize that following alterations regarding
peripheral O2 delivery and utilization may be associated
with the reduced peak C(a-v)O2 and the steeper ΔCO/
Δ _VO2 slope in PCOS women. First, endothelial dys-
function, which is an intrinsic feature of PCOS (Sprung
et al. 2013a), is associated with reduced exercise capac-
ity in women (Patel et al. 2005). Endothelial dysfunc-
tion may impair the appropriate exercise-induced
hyperemia in active muscles due to reduced bioavail-
ability of NO (Maxwell et al. 1998), and in fact, partic-
ularly NO-mediated microvascular vasodilator
dysfunction has recently been observed in PCOS
(Sprung et al. 2013b). In addition, exercise training has
been demonstrated to enhance NO-mediated endothelial
function with a parallel improvement in _VO2peak in
obese women with PCOS (Sprung et al. 2013b). For the
present, it is unresolved whether endothelial dysfunction
is associated with IR in PCOS (Sprung et al. 2013a).
We did not observe differences in exercise MAP or
SVRi between PCOS women and controls in our cur-
rent study. This suggests vascular conductance was not
limited at the whole-body level for PCOS women.
However, we cannot draw conclusions concerning exer-
cise-induced redistribution of blood flow between active
muscles and less active regions such as splanchnic cir-
culation, because local active muscle blood flow differs
considerably from systemically observed circulatory
responses during incremental exercise (Murias et al.
2013). Second, in conditions in which there is a skeletal
muscle oxidative defect, such as in mitochondrial myo-
pathies, the findings of reduced _VO2peak, reduced peak
C(a-v)O2, and a pronounced ΔCO/Δ _VO2 slope resemble
our findings in PCOS women (Taivassalo et al. 2003).
Defects in skeletal muscle insulin signaling pathways
(Dunaif et al. 2001; Corbould et al. 2005) and expres-
sion of genes involved in mitochondrial oxidative meta-
bolism (Skov et al. 2007) have been observed in women
with PCOS and pronounced IR, potentially reducing
responsiveness to glucose and O2 utilization within
skeletal muscles. However, primary function of skeletal
muscle mitochondria has also been reported to be
intact in PCOS (Eriksen et al. 2011; Rabøl et al. 2011).
Hence, it is unclear whether defects in mitochondrial
function could reduce O2 utilization and thus peak C
(a-v)O2 in PCOS women in this study.
PCOS per se does not limit systemic O2
delivery during exercise
SpO2 and CaO2 were similarly maintained in PCOS
women and controls throughout incremental exercise,
suggesting that alveolar gas exchange set no limitation to
systemic O2 delivery. In addition, after exhibiting the pro-
nounced response of CO to increasing O2 demand, PCOS
women attained similar CO and COi at peak exercise in
comparison with controls. We also calculated CPO (and
CPOi), which is an index of cardiac reserve and conveys
the hydraulic power of the heart by relating changes in
flow and afterload (Cooke et al. 1998): No differences
between PCOS women and controls were observed for
CPO and CPOi at peak exercise. Thus, while cardiac func-
tion has its vital role in the integrated system responding
for O2 transport (Wagner 2000), total blood flow and
cardiovascular system’s ability to generate an appropriate
response to increasing O2 demand were not further
diminished in PCOS women. In conclusion, PCOS per se
did not contribute to limitations of systemic O2 delivery
during exercise.
At rest before incremental exercise, higher CO but sim-
ilar COi were measured in PCOS women when compared
to controls. The difference in absolute CO at rest was
thus partly due to slight but nonsignificant differences in
anthropometry but also due to a nonsignificantly higher
mean of resting HR in PCOS women. Previous studies
have reported both diastolic (Yarali et al. 2001; Orio et al.
2004; Kosmala et al. 2008) and systolic (Kosmala et al.
2008) dysfunction as well as normal cardiac function
(Tekin et al. 2009; Rees et al. 2014) in women with PCOS
at rest in case–control echocardiographic studies. There
may be an inverse association between cardiac function
and the magnitude of IR in PCOS as associations between
cardiac dysfunction and IR have been observed in women
with PCOS (Yarali et al. 2001; Orio et al. 2004; Kosmala
et al. 2008). In addition, diastolic dysfunction was
recently found to be associated with IR in overweight and
obese women but PCOS itself did not contribute to the
dysfunction (Rees et al. 2014). Thus, our finding of simi-
lar cardiac function at peak exercise in PCOS women and
controls might be due to rather similar HOMA-IR in the
groups, albeit we did not find significant associations
between cardiac function and HOMA-IR (data not
shown).
Methodological considerations, strengths,
and limitations
The contribution of fat mass to O2 consumption is negli-
gible and independent of _VO2peak (Goran et al. 2000).
Instead, absolute _VO2peak (L/min) follows a linear func-
tion of FFM (Batterham et al. 1999; Krachler et al. 2015).
Scaling _VO2peak to FFM during cycling exercise was
recently demonstrated to introduce a much smaller bias
against obese women than quantifying _VO2peak with more
traditional methods (i.e., L/min, or mL/min/kg body
ª 2016 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
the American Physiological Society and The Physiological Society.
2016 | Vol. 4 | Iss. 4 | e12719
Page 9
A. P. E. Rissanen et al. Acute Exercise and Polycystic Ovary Syndrome
weight) (Krachler et al. 2015), although cycling is a non-
weight-bearing exercise mode. Thus, in our current study
involving overweight and obese women, we scaled _VO2 to
FFM to avoid ignoring any differences in body size and
composition between PCOS women and controls.
The strengths of this study included matching the sub-
ject groups for age, anthropometry, and LTPA. Moreover,
compared to invasive alternatives, the noninvasive meth-
ods used to monitor SpO2 and cardiac function were
probably more feasible to the subjects of this study. This
is relevant as a confidence in the ability to maintain exer-
cise might be impaired in PCOS due to diminished men-
tal health often related to the syndrome (Banting et al.
2014). However, PCOS women and controls similarly
made their maximal effort during the exercise test accord-
ing to RER and RPE data (Edvardsen et al. 2014), thus
indicating no particular signs of behavior affecting their
exercise performance.
One limitation of this study was the method used to
assess IR; using an oral glucose tolerance test or a eug-
lycemic–hyperinsulinemic clamp technique might have
provided a more in-depth assessment of insulin sensitiv-
ity. It is also notable that the hormonal profile of the
subjects was not determined separately for this study
because previous studies had not found consistent asso-
ciations between hormonal profile and _VO2peak (Orio
et al. 2006; Thomson et al. 2009) or hormonal profile
and cardiac function (Yarali et al. 2001; Orio et al. 2004;
Rees et al. 2014) in women with PCOS. It may be sug-
gested that hyperandrogenism did not have a major
effect on the findings of this study as only 27% (4/15)
of PCOS women had evidence of hyperandrogenism and
androgen levels in PCOS women were relatively low.
However, the impact of severe hyperandrogenism on
exercise responses in women with PCOS cannot be eval-
uated based on this study. The amount of LTPA was
determined by self-reporting, which is notable as over-
weight and obese individuals may overreport the amount
of their physical activity (Prince et al. 2008). However,
possible overreporting hardly affected matching our sub-
ject groups for LTPA and thus the conclusions drawn.
A fairly small sample size also limits this study by affect-
ing the statistical power of the results, highlighted in
correlation analyses. However, we had the statistical
power of 84.5% (P < 0.05) to detect the difference in
our main outcome ( _VO2peak) between PCOS women and
controls, indicating the difference did not result from
type I error.
Conclusions
Performing maximal incremental cycling exercise revealed
reduced _VO2peak, reduced C(a-v)O2 at peak exercise, and
a steeper ΔCO/Δ _VO2 slope in PCOS women when com-
pared to control women matched for age, anthropometry,
and physical activity. This can be regarded as an altered
cardiorespiratory response to exercise in PCOS women.
Eventually, PCOS women and controls attained similar
cardiac function at peak exercise, while CaO2 was simi-
larly maintained in the groups. In summary, these find-
ings indicate that PCOS per se is associated with
alterations in peripheral adjustments to exercise rather
than with limitations of systemic O2 delivery in over-
weight and obese women. Future studies are warranted to
identify detailed mechanisms of the altered peripheral
adjustments indicated here.
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